Literature DB >> 20460141

Increased striatal dopamine transporter levels, as indicated by a DAT scan, induced by ziprasidone in association to improvement of tardive dyskinesia--a case report.

E N Rizos, S Chatziioannou, N Siafakas, A Douzenis, E Katsantoni, A Mandrapilia, S Bacalis, C Fotiadis, L Lykouras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20460141     DOI： 10.1016/j.pnpbp.2010.05.001

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN： 0278-5846            Impact factor:   5.067


× No keyword cloud information.
  3 in total

1.  ECT in a patient with Parkinson's disease and schizophrenia, with dopamine transporter visualisation using 123I-ioflupane SPET.

Authors:  Paloma Fernández-Corcuera; Salvatore Aguilar; Víctor Viçens; Jaume Mora; Ana Benitez; Amparo García-Burillo; Edith Pomarol-Clotet; Peter McKenna
Journal:  J Neural Transm (Vienna)       Date:  2011-02-27       Impact factor: 3.575

2.  Resveratrol Protects Against Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine.

Authors:  Alcindo Busanello; Caroline Queiroz Leal; Luis Ricardo Peroza; Jivago Röpke; Elizete de Moraes Reis; Catiuscia Molz de Freitas; Milena Libardoni; Nilda Berenice de Vargas Barbosa; Roselei Fachinetto
Journal:  Neurochem Res       Date:  2017-07-25       Impact factor: 3.996

3.  Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.

Authors:  Jungjin Kim; Eric Macmaster; Thomas L Schwartz
Journal:  Drugs Context       Date:  2014-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.